Depression treatment for bipolar disorder

20% of some 7 million US patients with bipolar disorder commit suicide. US-Israeli company NRx is currently undergoing a US trial on 72 bipolar patients involving the simultaneous administering of two anti-depression treatments that do not have hallucinogenic side effects.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *